These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36532344)

  • 1. Predicting cross-protection against foot-and-mouth disease virus strains by serology after vaccination.
    Gubbins S; Paton DJ; Dekker A; Ludi AB; Wilsden G; Browning CFJ; Eschbaumer M; Barnabei J; Duque H; Pauszek LL; King DP
    Front Vet Sci; 2022; 9():1027006. PubMed ID: 36532344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted FMD Vaccines for Eastern Africa: The AgResults Foot and Mouth Disease Vaccine Challenge Project.
    Hammond JM; Maulidi B; Henning N
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen.
    Nagendrakumar SB; Srinivasan VA; Madhanmohan M; Yuvaraj S; Parida S; Di Nardo A; Horsington J; Paton DJ
    Vaccine; 2011 Feb; 29(10):1906-12. PubMed ID: 21236232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
    Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
    Vaccine; 2006 Apr; 24(16):3184-90. PubMed ID: 16488060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential antibody responses to the major antigenic sites of FMD virus serotype O after primo-vaccination, multiply-vaccination and after natural exposure.
    Biswal JK; Subramaniam S; Ranjan R; VanderWaal K; Sanyal A; Pattnaik B; Singh RK
    Infect Genet Evol; 2020 Mar; 78():104105. PubMed ID: 31706082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral Immune Response in Calves Vaccinated with Monovalent Vaccines or a Trivalent Combination Thereof and Matching of These Vaccines to the Selected Circulating Foot-and-Mouth Disease Viruses in Ethiopia.
    Woldemariyam FT; Negessu D; Bilata T; Muluneh A; Gebreweld DS; Ebisa IT; Paeshuyse J
    Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the calibration of serological assays using sera collected from cattle and sheep following a single dose of foot-and-mouth disease vaccine.
    Karabassova AS; Sultanov AA; Saduakassova MA; King DP; Ludi AB; Browning CFJ; Wilsden G
    Vet World; 2022 Feb; 15(2):524-530. PubMed ID: 35400944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel method for performing antigenic vaccine matching for foot-and-mouth disease in absence of the homologous virus.
    Sirdar MM; Fosgate GT; Blignaut B; Gummow B; Shileyi B; Lazarus DD; Mutowembwa P; van der Merwe D; Heath L
    Vaccine; 2019 Aug; 37(35):5025-5034. PubMed ID: 31296377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration.
    Tekleghiorghis T; Weerdmeester K; van Hemert-Kluitenberg F; Moormann RJ; Dekker A
    Vaccine; 2014 Sep; 32(41):5330-6. PubMed ID: 25092634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FMD vaccine matching: Inter laboratory study for improved understanding of r
    Willems T; De Vleeschauwer A; Perez-Filgueira M; Li Y; Ludi A; Lefebvre D; Wilsden G; Statham B; Haas B; Mattion N; Robiolo B; Beascoechea Perez C; Maradei E; Smitsaart E; La Torre J; De Clercq K
    J Virol Methods; 2020 Feb; 276():113786. PubMed ID: 31765721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges for Serology-Based Characterization of Foot-and-Mouth Disease Outbreaks in Endemic Areas; Identification of Two Separate Lineages of Serotype O FMDV in Uganda in 2011.
    Namatovu A; Belsham GJ; Ayebazibwe C; Dhikusooka MT; Wekesa SN; Siegismund HR; Muwanika VB; Tjørnehøj K
    Transbound Emerg Dis; 2015 Oct; 62(5):522-34. PubMed ID: 24118785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory.
    Paton DJ; Reeve R; Capozzo AV; Ludi A
    Vaccine; 2019 Sep; 37(37):5515-5524. PubMed ID: 31405637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serological response against foot and mouth disease virus elicited by repeated vaccination of dairy cattle.
    Elnekave E; Dekker A; Eble P; van Hemert-Kluitenberg F; Gelman B; Storm N; Klement E
    Vaccine; 2016 Sep; 34(41):4920-4926. PubMed ID: 27576078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency FMD Serotype O Vaccines Protect Cattle against Heterologous Challenge with a Variant Foot-and-Mouth Disease Virus from the O/ME-SA/Ind2001 Lineage.
    Singanallur NB; Dekker A; Eblé PL; van Hemert-Kluitenberg F; Weerdmeester K; Horsington JJ; Vosloo W
    Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response in dairy cattle against combined foot and mouth disease and haemorrhagic septicemia vaccine under field conditions.
    Muenthaisong A; Rittipornlertrak A; Nambooppha B; Tankaew P; Varinrak T; Pumpuang M; Muangthai K; Atthikanyaphak K; Singhla T; Pringproa K; Punyapornwithaya V; Sawada T; Sthitmatee N
    BMC Vet Res; 2021 May; 17(1):186. PubMed ID: 33952269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey.
    Knight-Jones TJ; Bulut AN; Gubbins S; Stärk KD; Pfeiffer DU; Sumption KJ; Paton DJ
    Vaccine; 2015 Feb; 33(6):805-11. PubMed ID: 25528523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad immunogenic spectrum of monovalent and trivalent foot-and-mouth disease virus vaccines containing O
    Malirat V; Caldevilla C; Cardillo S; Espinoza AM; Novo SG; Taffarel A; Benito MB; Bergmann IE
    Vaccine; 2023 Sep; 41(39):5782-5790. PubMed ID: 37574343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long term effect of age and maternally derived antibodies against foot and mouth disease on the serological response following vaccination in young dairy calves.
    Elnekave E; Dekker A; Eble P; van Hemert-Kluitenberg F; Gelman B; Storm N; Klement E
    Vaccine; 2016 Sep; 34(41):4927-4934. PubMed ID: 27521229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.